InMode Ltd. (NASDAQ:INMD) Receives $16.00 Consensus Target Price from Analysts

Shares of InMode Ltd. (NASDAQ:INMD) have been given a consensus recommendation of “Hold” by the eight ratings firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $16.00.

A number of brokerages have recently issued reports on INMD. Weiss Ratings restated a “sell (d+)” rating on shares of InMode in a report on Thursday, August 6th. Barclays set a $19.00 price objective on shares of InMode and gave the stock an “overweight” rating in a report on Thursday, May 7th. Finally, Robert W. Baird reduced their target price on shares of InMode from $17.00 to $14.00 and set a “neutral” rating on the stock in a report on Thursday, May 7th.

InMode Trading Down 0.2%

Shares of NASDAQ INMD opened at $14.99 on Friday. The stock has a market cap of $861.63 million, a PE ratio of 12.19 and a beta of 1.89. InMode has a 12-month low of $12.72 and a 12-month high of $16.74. The company has a 50-day moving average of $14.74 and a 200 day moving average of $14.29.

InMode (NASDAQ:INMD) last issued its earnings results on Wednesday, August 5th. The healthcare company reported $0.35 earnings per share for the quarter, hitting the consensus estimate of $0.35. InMode had a return on equity of 11.99% and a net margin of 20.69%.The business had revenue of $95.59 million for the quarter, compared to analysts’ expectations of $94.89 million. During the same period in the previous year, the firm posted $0.47 EPS. The business’s revenue for the quarter was up .0% compared to the same quarter last year.

Institutional Investors Weigh In On InMode

A number of large investors have recently modified their holdings of the company. Leonteq Securities AG acquired a new stake in shares of InMode during the fourth quarter worth about $26,000. Quadrant Capital Group LLC raised its stake in InMode by 127.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock valued at $29,000 after acquiring an additional 1,091 shares during the last quarter. Advisory Services Network LLC purchased a new stake in InMode during the 3rd quarter valued at approximately $37,000. Basepoint Wealth LLC acquired a new stake in InMode during the 4th quarter worth approximately $39,000. Finally, Deutsche Bank AG lifted its position in InMode by 35.9% during the 4th quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company’s stock worth $58,000 after acquiring an additional 1,037 shares during the period. 68.04% of the stock is owned by hedge funds and other institutional investors.

InMode Company Profile

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.